Lars Lau Raket

@LarsRaket

Statistician and data scientist working with brain disorders 🧠 📈 Views are my own.

Copenhagen, Denmark larslau.dk Joined March 2012

1.3K Following 439 Followers 714 Posts

Latest posts 5

Pinned post

Lars Lau Raket @LarsRaket Aug 13, 2020

My paper on statistical disease progression modeling in Alzheimer's disease has just been published in @FrontAIBigData. You can find it here doi.org/10.3389/fdata.… Want to try it out on your own data? Code can be found here github.com/larslau/progmod

Lars Lau Raket @LarsRaket Nov 10, 2025

🧠🧪✨Can we map the full timeline of biomarker changes in Alzheimer’s disease—from the earliest shifts (a decade before symptoms) to advanced dementia? Our new Brain paper says: Yes! Two large cohorts, one consistent story. (1/6)

🔗doi.org/10.1093/brain/…

academic.oup.com Estimating the time course of biomarker changes in Alzheimer’s disease Raket et al. study the time course of biomarker changes in Alzheimer's disease, from the earliest detectable changes—often appearing a decade prior to symp

Lars Lau Raket @LarsRaket Aug 1, 2024

I'm happy to share our paper on harmonizing tau PET in Alzheimer's disease that was just published in Alzheimer's & Dementia 🧠 📈 🚀
doi.org/10.1002/alz.13…
🧵[1/7]

alz-journals.onlinelibrary.wiley.com Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the... INTRODUCTION Tau-positron emission tomography (PET) outcome data of patients with Alzheimer's disease (AD) cannot currently be meaningfully compared or combined when different tracers are used due...

Lars Lau Raket @LarsRaket May 2, 2024

I am very excited to be taking on the role of chair of the @ISTAART Design and Data Analytics PIA. Looking forward to working with this all-star executive committee, all of the members, and the amazing Alzheimer’s Association staff!

🧠📈💥

Design and Data Analytics PIA @DesignDataPIA May 2, 2024

Congratulations to our new Executive Committee!🥳

Chair - @LarsRaket
Vice Chair - Heather Allore
Programs Chair - @maude_wagner2
Communications Chair - @JetMJVonk
Student/Postdoc Member - @ni_corv
Student/Postdoc Member - @natggoncalves
Immediate Past Chair - @DrAnaCapuano
View quoted post on X

Lars Lau Raket @LarsRaket Feb 28, 2024

📣 PAPER ALERT 🚨

Scenarios for the long-term efficacy of amyloid-targeting therapies in the context of the natural history of Alzheimer's disease
🧵 (1/7)

medrxiv.org/content/10.110…

www.medrxiv.org Scenarios for the long-term efficacy of amyloid-targeting therapies in the context of the natural... Importance Recent clinical trials of Aβ-targeting therapies in Alzheimer’s disease (AD) have demonstrated clinical benefit over 18-months, but their long-term impact on disease trajectory is not yet...